Local Therapy for Oligorecurrent and Oligometastatic Esophageal Squamous Cell Carcinoma

NCT03904927 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

104

Enrollment

OTHER

Sponsor class

Conditions

Oligorecurrent and Oligometastatic Esophageal Squamous Cell Carcinoma

Interventions

OTHER: Radiation, Surgery or Radiofrequency ablation
DRUG: Systemic therapy

Sponsor

Fudan University